Researchers created nanoparticles combining caffeic acid (a plant compound) with vanadium that reduced oxidative stress and inflammation in lab and animal models of skin flap transplants. The particles reduced harmful free radicals, lowered inflammatory markers (CCL4 and CXCL2), and improved skin flap survival rates in animal tests. This is early-stage research—it hasn't been tested on human skin yet.

Scientists made caffeic acid-vanadium nanoparticles in a lab and tested them in cell cultures exposed to oxidative stress and inflammatory triggers, then in animal models of skin flap transplantation to measure survival rates.

Funding not disclosed in abstract